Analysis
Dabigatran, bleeding, and the regulators
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4517 (Published 23 July 2014) Cite this as: BMJ 2014;349:g4517
Related articles
- Feature Published: 23 July 2014; BMJ 349 doi:10.1136/bmj.g4670
- Feature Published: 23 July 2014; BMJ 349 doi:10.1136/bmj.g4747
- Editor's Choice Published: 24 July 2014; BMJ 349 doi:10.1136/bmj.g4793
- Research Published: 24 April 2015; BMJ 350 doi:10.1136/bmj.h1585
See more
- David Oliver: What the plan for social care omittedBMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227
- Stroke: “striking reductions” are seen in number of people with symptoms seeking helpBMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406
- NICE recommends implantable monitor to identify atrial fibrillation after strokeBMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133
- Thrombectomy can be considered up to 24 hours after onset of stroke, says NICEBMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
- Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry)BMJ March 09, 2018, 360 k949; DOI: https://doi.org/10.1136/bmj.k949
Cited by...
- MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
- Periprocedural management of patients receiving novel oral anticoagulants
- Letter by Heinrich-Nols and Kreuzer Regarding Article, "Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial"
- Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial
- Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort study
- Clinical utility of dabigatran in United Arab Emirates: A pharmacovigilance study
- New oral anticoagulants: dosing and monitoring
- To Monitor Dabigatran or Not: A Matter of Patient Safety
- Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
- Novel oral anticoagulants: too good to be true?
- The trouble with dabigatran